Company profile
Tekla Life Sciences Investors
NYSE: HQL · Financial Services · Asset Management
PublicHQ Philadelphia, MACIK 0000884121Reports USD
#1 of 1,013 Financial Services companies by revenue
EA Score
——FH —DQ —GM —SS 83
v0.1 · 5/100 weight · pillars only
↑ listing tenure, market scale · ↓ Piotroski F, market scale
Methodology →Revenue TTM
$79.8M
Rev growth YoY (TTM)
+44.5%
Net income (FY)
—
Employees
—
as of 2026-08-11
Market cap
$633.1M
as of 2026-08-11
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Tekla Life Sciences Investors’s financial profile?
Tekla Life Sciences Investors has no structured financials on file — private or non-XBRL filer.
Peers · Financial Services
Red River Bancshares, Inc.——Gladstone Investment Corp.——Arrow Financial Corporation——Third Coast Bancshares, Inc.——Nuveen Churchill Direct Lending Corp.——Capital Bancorp, Inc.——Key facts
CEODaniel R. Omstead
SectorFinancial Services
IndustryAsset Management
HeadquartersPhiladelphia, MA
ExchangeNYSE: HQL
Employees—
IPO date1992-05-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.